PharmacyCodes



Cafilon en es it fr

Cafilon Brand names, Cafilon Analogs

Cafilon Brand Names Mixture

  • No information avaliable

Cafilon Chemical_Formula

C11H15NO

Cafilon RX_link

No information avaliable

Cafilon fda sheet

Cafilon msds (material safety sheet)

Cafilon MSDS

Cafilon Synthesis Reference

No information avaliable

Cafilon Molecular Weight

177.243 g/mol

Cafilon Melting Point

139 oC

Cafilon H2O Solubility

>5 mg/L

Cafilon State

Solid

Cafilon LogP

1.796

Cafilon Dosage Forms

Tablet

Cafilon Indication

Used as an anorectic in the treatment of obesity.

Cafilon Pharmacology

Phenmetrazine is a sympathomimetic drug used primarily as an appetite depressant. Its actions and mechanisms are similar to dextroamphetamine. Amphetamines are non-catecholamine sympathomimetic amines with CNS stimulant activity. Phenmetrazine was originally sold under the tradename Preludin as an anorectic. It has since been removed from the market. It is by some considered to have a greater potential for addiction than the amphetamines, and has been abused in many countries, for example Sweden.

Cafilon Absorption

Readily absorbed from the gastro-intestinal tract and buccal mucosa.

Cafilon side effects and Toxicity

Adult monkeys have an LD50 of 15 to 20 mg/kg, whereas for young monkeys the LD50 is only 5 mg/kg. Symptoms of overdose include acute central nervous system stimulation, cardiotoxicity causing tachycardia, arrhythmias, hypertension, and cardiovascular collapse. Whilst some patients show signs of toxicity at blood concentrations of 20 µg/L, chronic abusers of amphetamine have been known to have blood concentration of up to 3000 µg/L.

Cafilon Patient Information

No information avaliable

Cafilon Organisms Affected

Humans and other mammals